RPG Life Sciences Limited

RPGLIFE Stock View

(NSE)

666.25

1,101.91
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for RPG Life Sciences Limited stands at 7 against 8, three months back.

RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets-branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas including nephrology, oncology, respiratory, vitamins and minerals, gastrointestinal and pain management, among others. The international formulations business operates in the generics and branded generics space across the regulated and emerging markets. Its branded generics space focuses on therapeutic areas, including nephrology, gastroenterology, and complex vertebral malformation (CVM) disorders. The API product line offers a range of synthetic APIs in the general therapeutic category.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
565.72
100 DMA ()
556.81
200 DMA ()
577.67
52 Weeks Range
450.55
752.45
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity